EN
|
LT
| Trade mark | ||
|---|---|---|
| (210) | Application number | 2021 1074 |
| (220) | Date of filing the application | 2021-05-17 |
| (111) | Registration number | 85854 |
| (151) | Registration date | 2021-12-14 |
| (181) | Expire | 2031-05-17 |
| (442) | Date of application publication, bulletin No. | 2021-08-25, 2021/16 |
| (450) | Date of registration publication, bulletin No. | 2021-12-27, 2021/24 |
| Legal status |
Registered
|
|
| Reproduction of the mark | ||
| (540) |
ODIFLAN
|
|
| (531) | Indication of Vienna Classification | 27.05.01 |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 farmaciniai preparatai ir medžiagos. |
|
| Applicant (731) / Owner (732) | ||
| (732) | Name | Teva Pharmaceuticals Europe B.V. |
| Address | Piet Heinkade 107, NL-1019 GM Amsterdam | |
| Country | NL | |
| Attorney or representative | ||
| (740) | Name | UAB "MSP Europe", Juozas Lapienis |
| Address | Šeimyniškių g. 21-92, 09236 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | |
| Date | ||
| Country | ||